ID   CCN3_RAT                Reviewed;         351 AA.
AC   Q9QZQ5;
DT   19-OCT-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   24-JUL-2024, entry version 152.
DE   RecName: Full=CCN family member 3 {ECO:0000305};
DE   AltName: Full=Cellular communication network factor 3 {ECO:0000250|UniProtKB:P48745};
DE   AltName: Full=Nephroblastoma-overexpressed gene protein homolog;
DE   AltName: Full=Protein NOV homolog;
DE            Short=NovH;
DE   Flags: Precursor;
GN   Name=Ccn3; Synonyms=Nov {ECO:0000312|RGD:621553};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND TISSUE SPECIFICITY.
RC   STRAIN=Sprague-Dawley;
RX   PubMed=10570975; DOI=10.1016/s0378-1119(99)00364-9;
RA   Liu C., Liu X.J., Crowe P.D., Kelner G.S., Fan J., Barry G., Manu F.,
RA   Ling N., De Souza E.B., Maki R.A.;
RT   "Nephroblastoma overexpressed gene (NOV) codes for a growth factor that
RT   induces protein tyrosine phosphorylation.";
RL   Gene 238:471-478(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Heart;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   INTERACTION WITH GJA1.
RX   PubMed=15181016; DOI=10.1074/jbc.m404073200;
RA   Gellhaus A., Dong X., Propson S., Maass K., Klein-Hitpass L., Kibschull M.,
RA   Traub O., Willecke K., Perbal B., Lye S.J., Winterhager E.;
RT   "Connexin43 interacts with NOV: a possible mechanism for negative
RT   regulation of cell growth in choriocarcinoma cells.";
RL   J. Biol. Chem. 279:36931-36942(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, INTERACTION WITH GJA1, AND TISSUE SPECIFICITY.
RX   PubMed=15213231; DOI=10.1074/jbc.m403952200;
RA   Fu C.T., Bechberger J.F., Ozog M.A., Perbal B., Naus C.C.;
RT   "CCN3 (NOV) interacts with connexin43 in C6 glioma cells: possible
RT   mechanism of connexin-mediated growth suppression.";
RL   J. Biol. Chem. 279:36943-36950(2004).
RN   [5]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=21871891; DOI=10.1016/j.febslet.2011.08.024;
RA   Janune D., Kubota S., Nishida T., Kawaki H., Perbal B., Iida S.,
RA   Takigawa M.;
RT   "Novel effects of CCN3 that may direct the differentiation of
RT   chondrocytes.";
RL   FEBS Lett. 585:3033-3040(2011).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY
RP   INFLAMMATORY PAIN.
RX   PubMed=22353423; DOI=10.1186/1742-2094-9-36;
RA   Kular L., Rivat C., Lelongt B., Calmel C., Laurent M., Pohl M., Kitabgi P.,
RA   Melik-Parsadaniantz S., Martinerie C.;
RT   "NOV/CCN3 attenuates inflammatory pain through regulation of matrix
RT   metalloproteinases-2 and -9.";
RL   J. Neuroinflamm. 9:36-36(2012).
CC   -!- FUNCTION: Immediate-early protein playing a role in various cellular
CC       processes including proliferation, adhesion, migration, differentiation
CC       and survival. Acts by binding to integrins or membrane receptors such
CC       as NOTCH1. Essential regulator of hematopoietic stem and progenitor
CC       cell function. Inhibits myogenic differentiation through the activation
CC       of Notch-signaling pathway. Inhibits vascular smooth muscle cells
CC       proliferation by increasing expression of cell-cycle regulators such as
CC       CDKN2B or CDKN1A independently of TGFB1 signaling. Ligand of integrins
CC       ITGAV:ITGB3 and ITGA5:ITGB1, acts directly upon endothelial cells to
CC       stimulate pro-angiogenic activities and induces angiogenesis. In
CC       endothelial cells, supports cell adhesion, induces directed cell
CC       migration (chemotaxis) and promotes cell survival. Also plays a role in
CC       cutaneous wound healing acting as integrin receptor ligand. Supports
CC       skin fibroblast adhesion through ITGA5:ITGB1 and ITGA6:ITGB1 and
CC       induces fibroblast chemotaxis through ITGAV:ITGB5. Seems to enhance
CC       bFGF-induced DNA synthesis in fibroblasts (By similarity). Involved in
CC       bone regeneration as a negative regulator (By similarity). Enhances the
CC       articular chondrocytic phenotype, whereas it repressed the one
CC       representing endochondral ossification (PubMed:21871891). Impairs
CC       pancreatic beta-cell function, inhibits beta-cell proliferation and
CC       insulin secretion (By similarity). Plays a role as negative regulator
CC       of endothelial pro-inflammatory activation reducing monocyte adhesion,
CC       its anti-inflammatory effects occur secondary to the inhibition of NF-
CC       kappaB signaling pathway (By similarity). Contributes to the control
CC       and coordination of inflammatory processes in atherosclerosis (By
CC       similarity). Attenuates inflammatory pain through regulation of
CC       IL1B- and TNF-induced MMP9, MMP2 and CCL2 expression. Inhibits MMP9
CC       expression through ITGB1 engagement (PubMed:22353423).
CC       {ECO:0000250|UniProtKB:P48745, ECO:0000250|UniProtKB:Q64299,
CC       ECO:0000269|PubMed:21871891, ECO:0000269|PubMed:22353423}.
CC   -!- SUBUNIT: Interacts with FBLN1. Interacts (via CTCK domain) with NOTCH1
CC       (via the EGF-like repeat region) (By similarity). Interacts with
CC       GJA1/CX43 (PubMed:15181016, PubMed:15213231). Interacts with
CC       ITGA5:ITGB1, ITGAV:ITGB3 and ITGAV:ITGB5 (By similarity). Interacts
CC       with ZDHHC22; the interaction may lead to CCN3 palmitoylation (By
CC       similarity). {ECO:0000250|UniProtKB:P48745,
CC       ECO:0000250|UniProtKB:Q64299, ECO:0000269|PubMed:15181016,
CC       ECO:0000269|PubMed:15213231}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000269|PubMed:15213231}. Cytoplasm
CC       {ECO:0000269|PubMed:15213231, ECO:0000269|PubMed:22353423}. Cell
CC       junction, gap junction {ECO:0000269|PubMed:15213231}. Note=Localizes at
CC       the gap junction in presence of GJA1. {ECO:0000269|PubMed:15213231}.
CC   -!- TISSUE SPECIFICITY: Widely expressed. Highly expressed in neurons of
CC       dorsal root ganglia and dorsal horn of the spinal cord (at protein
CC       level) (PubMed:22353423). Expressed in astrocytes (at protein level)
CC       (PubMed:15213231). In cartilage, dominantly expressed in the
CC       chondrocyte territorial matrix (PubMed:21871891).
CC       {ECO:0000269|PubMed:10570975, ECO:0000269|PubMed:15213231,
CC       ECO:0000269|PubMed:21871891, ECO:0000269|PubMed:22353423}.
CC   -!- INDUCTION: During persistent inflammatory pain the expression levels
CC       are down-regulated. {ECO:0000269|PubMed:22353423}.
CC   -!- PTM: May be palmitoylated on Cys-238, which is important for
CC       extracellular secretion. {ECO:0000250|UniProtKB:Q64299}.
CC   -!- SIMILARITY: Belongs to the CCN family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF171936; AAD49371.1; -; mRNA.
DR   EMBL; BC072548; AAH72548.1; -; mRNA.
DR   RefSeq; NP_110495.1; NM_030868.2.
DR   PDB; 5NB8; X-ray; 2.10 A; A/B/C/D=100-195.
DR   PDB; 6RK1; X-ray; 1.63 A; A/B=195-249.
DR   PDBsum; 5NB8; -.
DR   PDBsum; 6RK1; -.
DR   AlphaFoldDB; Q9QZQ5; -.
DR   SMR; Q9QZQ5; -.
DR   STRING; 10116.ENSRNOP00000011904; -.
DR   GlyCosmos; Q9QZQ5; 2 sites, No reported glycans.
DR   GlyGen; Q9QZQ5; 2 sites.
DR   PhosphoSitePlus; Q9QZQ5; -.
DR   PaxDb; 10116-ENSRNOP00000011904; -.
DR   Ensembl; ENSRNOT00000011904.6; ENSRNOP00000011904.3; ENSRNOG00000008697.6.
DR   Ensembl; ENSRNOT00055037413; ENSRNOP00055030497; ENSRNOG00055021821.
DR   Ensembl; ENSRNOT00060005178; ENSRNOP00060003814; ENSRNOG00060003150.
DR   Ensembl; ENSRNOT00065024797; ENSRNOP00065019380; ENSRNOG00065014985.
DR   GeneID; 81526; -.
DR   KEGG; rno:81526; -.
DR   UCSC; RGD:621553; rat.
DR   AGR; RGD:621553; -.
DR   CTD; 4856; -.
DR   RGD; 621553; Ccn3.
DR   eggNOG; ENOG502QR9V; Eukaryota.
DR   GeneTree; ENSGT00940000159963; -.
DR   HOGENOM; CLU_063247_1_0_1; -.
DR   InParanoid; Q9QZQ5; -.
DR   OMA; CACHTNC; -.
DR   OrthoDB; 2970572at2759; -.
DR   PhylomeDB; Q9QZQ5; -.
DR   TreeFam; TF326070; -.
DR   PRO; PR:Q9QZQ5; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000008697; Expressed in Ammon's horn and 20 other cell types or tissues.
DR   GO; GO:0030424; C:axon; IDA:RGD.
DR   GO; GO:0062023; C:collagen-containing extracellular matrix; IDA:RGD.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IDA:RGD.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IDA:UniProtKB.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0005921; C:gap junction; IDA:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IEA:Ensembl.
DR   GO; GO:0043025; C:neuronal cell body; IDA:RGD.
DR   GO; GO:0008083; F:growth factor activity; TAS:RGD.
DR   GO; GO:0008201; F:heparin binding; IBA:GO_Central.
DR   GO; GO:0005178; F:integrin binding; ISO:RGD.
DR   GO; GO:0005112; F:Notch binding; ISO:RGD.
DR   GO; GO:0001525; P:angiogenesis; ISS:UniProtKB.
DR   GO; GO:1990523; P:bone regeneration; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IBA:GO_Central.
DR   GO; GO:0033627; P:cell adhesion mediated by integrin; ISS:UniProtKB.
DR   GO; GO:0060326; P:cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0002062; P:chondrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0035767; P:endothelial cell chemotaxis; ISS:UniProtKB.
DR   GO; GO:0071603; P:endothelial cell-cell adhesion; ISS:UniProtKB.
DR   GO; GO:0010761; P:fibroblast migration; ISS:UniProtKB.
DR   GO; GO:0061484; P:hematopoietic stem cell homeostasis; ISO:RGD.
DR   GO; GO:0030308; P:negative regulation of cell growth; ISS:UniProtKB.
DR   GO; GO:1902731; P:negative regulation of chondrocyte proliferation; ISS:UniProtKB.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; ISS:UniProtKB.
DR   GO; GO:0046676; P:negative regulation of insulin secretion; ISS:UniProtKB.
DR   GO; GO:0090027; P:negative regulation of monocyte chemotaxis; ISS:UniProtKB.
DR   GO; GO:0010832; P:negative regulation of myotube differentiation; ISS:UniProtKB.
DR   GO; GO:1901223; P:negative regulation of non-canonical NF-kappaB signal transduction; ISS:UniProtKB.
DR   GO; GO:1904057; P:negative regulation of sensory perception of pain; IMP:UniProtKB.
DR   GO; GO:0060392; P:negative regulation of SMAD protein signal transduction; ISS:UniProtKB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IBA:GO_Central.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; ISS:UniProtKB.
DR   GO; GO:0010468; P:regulation of gene expression; IDA:MGI.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   GO; GO:0014909; P:smooth muscle cell migration; ISS:UniProtKB.
DR   GO; GO:0048659; P:smooth muscle cell proliferation; ISS:UniProtKB.
DR   GO; GO:0044342; P:type B pancreatic cell proliferation; ISS:UniProtKB.
DR   Gene3D; 2.10.70.10; Complement Module, domain 1; 1.
DR   Gene3D; 2.20.100.10; Thrombospondin type-1 (TSP1) repeat; 1.
DR   InterPro; IPR050941; CCN.
DR   InterPro; IPR006207; Cys_knot_C.
DR   InterPro; IPR006208; Glyco_hormone_CN.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR000867; IGFBP-like.
DR   InterPro; IPR012395; IGFBP_CNN.
DR   InterPro; IPR017891; Insulin_GF-bd_Cys-rich_CS.
DR   InterPro; IPR043973; TSP1_CCN.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   InterPro; IPR001007; VWF_dom.
DR   PANTHER; PTHR11348:SF8; CCN FAMILY MEMBER 3; 1.
DR   PANTHER; PTHR11348; CONNECTIVE TISSUE GROWTH FACTOR-RELATED; 1.
DR   Pfam; PF00007; Cys_knot; 1.
DR   Pfam; PF00219; IGFBP; 1.
DR   Pfam; PF19035; TSP1_CCN; 1.
DR   Pfam; PF00093; VWC; 1.
DR   PIRSF; PIRSF036495; IGFBP_rP_CNN; 1.
DR   SMART; SM00041; CT; 1.
DR   SMART; SM00121; IB; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF57603; FnI-like domain; 1.
DR   SUPFAM; SSF57184; Growth factor receptor domain; 1.
DR   SUPFAM; SSF82895; TSP-1 type 1 repeat; 1.
DR   PROSITE; PS01185; CTCK_1; 1.
DR   PROSITE; PS01225; CTCK_2; 1.
DR   PROSITE; PS00222; IGFBP_N_1; 1.
DR   PROSITE; PS51323; IGFBP_N_2; 1.
DR   PROSITE; PS50092; TSP1; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Cell junction; Cytoplasm; Disulfide bond; Gap junction;
KW   Glycoprotein; Growth factor; Lipoprotein; Palmitate; Reference proteome;
KW   Secreted; Signal.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..351
FT                   /note="CCN family member 3"
FT                   /id="PRO_0000014417"
FT   DOMAIN          25..99
FT                   /note="IGFBP N-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DOMAIN          102..168
FT                   /note="VWFC"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00220"
FT   DOMAIN          199..244
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DOMAIN          258..332
FT                   /note="CTCK"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00039"
FT   LIPID           238
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q64299"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        274
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        29..55
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        33..57
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        37..58
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        44..61
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        69..83
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        75..96
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00653"
FT   DISULFID        258..295
FT                   /evidence="ECO:0000250"
FT   DISULFID        275..309
FT                   /evidence="ECO:0000250"
FT   DISULFID        286..325
FT                   /evidence="ECO:0000250"
FT   DISULFID        289..327
FT                   /evidence="ECO:0000250"
FT   DISULFID        294..331
FT                   /evidence="ECO:0000250"
FT   STRAND          104..106
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          109..111
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          123..128
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          131..138
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          149..155
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          164..167
FT                   /evidence="ECO:0007829|PDB:5NB8"
FT   STRAND          213..223
FT                   /evidence="ECO:0007829|PDB:6RK1"
FT   STRAND          232..241
FT                   /evidence="ECO:0007829|PDB:6RK1"
SQ   SEQUENCE   351 AA;  38510 MW;  02619707DE7C1BFB CRC64;
     MSVFLRKQCL CLGFLLLHLL NQVSATLRCP SRCPSQCPSI SPTCAPGVRS VLDGCSCCPV
     CARQRGESCS EMRPCDQSSG LYCDRSADPN NETGICMVPE GDNCVFDGVI YRNGEKFEPN
     CQYHCTCRDG QIGCVPRCQL DVLLPGPDCP APKKVAVPGE CCEKWTCGSE EKGTLGGLAL
     PAYRPEATVG VELSDSSINC IEQTTEWSAC SKSCGMGLST RVTNRNLQCE MVKQTRLCMV
     RPCEQEPGEA TDMKGKKCLR TKKSLKSIHL QFKNCTSLYT YKPRFCGICS DGRCCTPFNT
     KTIQVEFQCL PGQIIKKPVM VIGTCTCHSN CPQNNEAFLQ ELELKTSRGE M
//
